Ruffer’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.3M Buy
+14,639
New +$11.1M 0.32% 76
2025
Q4
– Sell
-21,540
Closed -$12.1M – 173
2025
Q3
$12.1M Buy
+21,540
New +$12.2M 0.67% 37

Other funds holding REGN

Ruffer's REGN Position: Q3 2026 in Review

Ruffer opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 14,639 shares worth $6.3M. The stake represents 0.32% of the portfolio and ranks #76 among its holdings. This is a return to the name: Ruffer previously reported a position in REGN as recently as Q3 2025.

Ruffer first reported a position in REGN in Q3 2025 and has held it in 2 quarters since. The position peaked at $12.1M in Q3 2025. 1,212 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Ruffer held 14,639 shares of Regeneron Pharmaceuticals worth $6.3M as of Q3 2026.
  • Regeneron Pharmaceuticals was a new Ruffer position in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.32% of Ruffer's portfolio in Q3 2026, its #76 holding.
  • Ruffer first reported a position in Regeneron Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • Ruffer's Regeneron Pharmaceuticals position peaked at $12.1M in Q3 2025.
  • 1,212 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Ruffer's 13F filing for Q3 2026, filed 10 Nov 2026.